Healthequity Inc (HQY) Given Average Recommendation of “Buy” by Brokerages

Healthequity Inc (NASDAQ:HQY) has been given an average recommendation of “Buy” by the thirteen research firms that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $66.33.

A number of research analysts recently issued reports on HQY shares. SunTrust Banks raised their target price on shares of Healthequity to $70.00 and gave the company a “buy” rating in a research note on Tuesday, March 20th. Oppenheimer raised their target price on shares of Healthequity from $58.00 to $68.00 and gave the company an “outperform” rating in a research note on Tuesday, March 20th. JPMorgan Chase lowered their target price on shares of Healthequity from $52.00 to $51.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 24th. Zacks Investment Research upgraded shares of Healthequity from a “hold” rating to a “buy” rating and set a $68.00 target price on the stock in a research note on Tuesday, April 3rd. Finally, Barrington Research raised their target price on shares of Healthequity to $65.00 and gave the company an “outperform” rating in a research note on Tuesday, March 20th.

In other Healthequity news, EVP Gary D. Robinson sold 1,500 shares of the stock in a transaction on Thursday, April 5th. The shares were sold at an average price of $63.85, for a total value of $95,775.00. Following the completion of the sale, the executive vice president now directly owns 4,490 shares of the company’s stock, valued at approximately $286,686.50. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Ashley Dreier sold 71,157 shares of the stock in a transaction on Thursday, March 22nd. The shares were sold at an average price of $65.48, for a total transaction of $4,659,360.36. Following the completion of the sale, the vice president now directly owns 21,059 shares of the company’s stock, valued at $1,378,943.32. The disclosure for this sale can be found here. Insiders sold a total of 736,581 shares of company stock worth $39,508,893 over the last quarter. 29.00% of the stock is currently owned by company insiders.



A number of institutional investors have recently modified their holdings of the business. NBW Capital LLC boosted its holdings in Healthequity by 1.5% in the 4th quarter. NBW Capital LLC now owns 69,137 shares of the company’s stock valued at $3,226,000 after purchasing an additional 1,001 shares during the period. Advisory Services Network LLC boosted its holdings in Healthequity by 4.1% in the 4th quarter. Advisory Services Network LLC now owns 31,425 shares of the company’s stock valued at $1,466,000 after purchasing an additional 1,230 shares during the period. UBS Asset Management Americas Inc. boosted its holdings in Healthequity by 4.3% in the 4th quarter. UBS Asset Management Americas Inc. now owns 32,586 shares of the company’s stock valued at $1,520,000 after purchasing an additional 1,348 shares during the period. Louisiana State Employees Retirement System boosted its holdings in Healthequity by 6.8% in the 4th quarter. Louisiana State Employees Retirement System now owns 22,100 shares of the company’s stock valued at $1,031,000 after purchasing an additional 1,400 shares during the period. Finally, Piedmont Investment Advisors LLC boosted its holdings in Healthequity by 15.9% in the 3rd quarter. Piedmont Investment Advisors LLC now owns 11,105 shares of the company’s stock valued at $562,000 after purchasing an additional 1,520 shares during the period. 99.17% of the stock is owned by hedge funds and other institutional investors.

Shares of HQY traded down $0.25 during mid-day trading on Friday, hitting $63.99. 74,686 shares of the company’s stock were exchanged, compared to its average volume of 667,219. Healthequity has a twelve month low of $40.21 and a twelve month high of $68.75. The firm has a market cap of $3,866.19, a price-to-earnings ratio of 118.28, a price-to-earnings-growth ratio of 2.54 and a beta of 1.39.

Healthequity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, March 19th. The company reported $0.06 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.06. Healthequity had a net margin of 20.64% and a return on equity of 13.47%. The company had revenue of $60.44 million for the quarter, compared to analyst estimates of $58.46 million. research analysts anticipate that Healthequity will post 0.77 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Healthequity Inc (HQY) Given Average Recommendation of “Buy” by Brokerages” was published by Dakota Financial News and is the property of of Dakota Financial News. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://dakotafinancialnews.com/2018/04/13/healthequity-inc-hqy-given-average-recommendation-of-buy-by-brokerages-6.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply